Immunotherapy for HER2-positive breast cancer: recent advances and combination therapeutic approaches

Nehad M Ayoub,1 Kamal M Al-Shami,2 Rami J Yaghan3 1Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology (JUST), Irbid, Jordan; 2Department of Drug Discovery and Development, Harrison School of Pharmacy, Auburn University, Auburn, AL, USA; 3Department of G...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ayoub NM, Al-Shami KM, Yaghan RJ
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2019
Materias:
Acceso en línea:https://doaj.org/article/5fb05676bd394ccdbb48619e7081b012
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares